Publication | Closed Access

Use of Yttrium-90 Glass Microspheres (TheraSphere) for the Treatment of Unresectable Hepatocellular Carcinoma in Patients with Portal Vein Thrombosis

Surgical OncologyPortal Vein ThrombosisHepatologyYttrium-90 Glass MicrospheresLiver CancerLiver TransplantationMedicineRadiation OncologyUnresectable Hepatocellular CarcinomaHepatocellular CarcinomaRadiologyHealth Sciences